Ticlopidine, Platelets and Vascular Disease

Nonfiction, Health & Well Being, Medical, Medical Science, Pharmacology, Specialties, Internal Medicine, Cardiology
Cover of the book Ticlopidine, Platelets and Vascular Disease by , Springer New York
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9781461383062
Publisher: Springer New York Publication: December 6, 2012
Imprint: Springer Language: English
Author:
ISBN: 9781461383062
Publisher: Springer New York
Publication: December 6, 2012
Imprint: Springer
Language: English

Blood platelets lack a nucleus. As a result their life span is short and they cannot reproduce themselves. Platelets share these qualities with the red blood cell. Plate­ lets and red blood cells, nevertheless, serve vital roles in the body. One major function of the platelet is its capacity to aggregate and thereby initiate intravas­ cular coagulation which often underlies such major diseases as myocardial infarc­ tion, cerebral infarction, and pulmonary embolism. For this reason in recent years, medical attention has been directed to drugs that inhibit platelet aggregation. Aspirin was the first drug to be proven effective in this area. Since then other drugs that share aspirin's fundamental biochemical action, inhibition of platelet cyclooxygenase, have also been studied. Very recently, ticlopidine, the first of what promises to be a new class of drugs inhibiting platelet aggregation and coagulation via an entirely different biochemical mechanism, has been exten­ sively studied and clinically shown to be as effective or more effective than aspirin in the prevention of ischemic cardiovascular and cerebrovascular disease.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

Blood platelets lack a nucleus. As a result their life span is short and they cannot reproduce themselves. Platelets share these qualities with the red blood cell. Plate­ lets and red blood cells, nevertheless, serve vital roles in the body. One major function of the platelet is its capacity to aggregate and thereby initiate intravas­ cular coagulation which often underlies such major diseases as myocardial infarc­ tion, cerebral infarction, and pulmonary embolism. For this reason in recent years, medical attention has been directed to drugs that inhibit platelet aggregation. Aspirin was the first drug to be proven effective in this area. Since then other drugs that share aspirin's fundamental biochemical action, inhibition of platelet cyclooxygenase, have also been studied. Very recently, ticlopidine, the first of what promises to be a new class of drugs inhibiting platelet aggregation and coagulation via an entirely different biochemical mechanism, has been exten­ sively studied and clinically shown to be as effective or more effective than aspirin in the prevention of ischemic cardiovascular and cerebrovascular disease.

More books from Springer New York

Cover of the book Optimal Learning Environments to Promote Student Engagement by
Cover of the book Propagation Engineering in Wireless Communications by
Cover of the book Muscle Imaging in Health and Disease by
Cover of the book Residue Reviews / Rückstands-Berichte by
Cover of the book Life After Residency by
Cover of the book A Commentary on Thermodynamics by
Cover of the book Thyroid Hormone Disruption and Neurodevelopment by
Cover of the book English for Presentations at International Conferences by
Cover of the book Fibonacci’s Liber Abaci by
Cover of the book Hidden Harmony—Geometric Fantasies by
Cover of the book International Handbook of Peace and Reconciliation by
Cover of the book The Pediatric Spine I by
Cover of the book Pediatric Nuclear Medicine and Molecular Imaging by
Cover of the book Franchisees as Consumers by
Cover of the book Polycystic Kidney Disease by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy